September 22, 2016
Namzaric is a fixed-dose combination of memantine and 10 mg donepezil hydrochloride indicated to treat moderate to severe Alzheimer’s disease in patients stabilized on 10 mg of donepezil hydrochloride.
September 21, 2016

Invokamet XR is Janssen’s once-daily, extended-release combination therapy of Invokana (canagliflozin) and metformin, the company announced Wednesday.

September 21, 2016

The Pharmaceutical Research and Manufacturers of America (PhRMA) on Wednesday brought 60 of its member companies’ researchers to Capitol Hill for meetings with members of Congress.

September 21, 2016

ATLANTA - The total economic burden attributed to opioid abuse exceeds $78 billion, according to a recent report published in Medical Daily. "More than 40 Americans die each day from overdoses involving prescription opioids. Families and communities continue to be devastated by the epidemic of prescription opioid overdoses." Tom Frieden, director Centers for Disease Control Director shared with Medical Daily. "The rising cost of the epidemic is also a tremendous burden for the health care system." (Medical Daily)

September 20, 2016

Drug maker KVK Tech said its Lomaira is aimed at providing an affordable medicine to aid in weight reduction, with a patient access program that lowers the cost for qualifying patients to no more than $0.50 per tablet during treatment. 

September 20, 2016

GSK's CEO Designate joined GSK in 2010 from L’Oréal where, over the course of her 17-year career, she held a variety of marketing and general management roles in the United Kingdom, Europe and the United States.

September 15, 2016

Currently, the drug comes with a boxed warning regarding serious neuropsychiatric adverse events, and the recommendation to remove it comes after the completion of an Evaluating Adverse Events in Global Smoking Cessation Study (EAGLES) evaluating its safety.

September 14, 2016
Allergan said that, pending approvals, it expects the transaction to close by the end of 2016. 
September 14, 2016
Cuvitru is able to infuse up to 60 mL per site and 60 mL per hour, per site as tolerated, which Shire said results in fewer infusion sites and shorter infusion durations. 
September 14, 2016

Seven out of 10 U.S. adults ages 65 and older have high blood pressure (140/90mmHg or higher), but nearly half do not have their blood pressure under control.

September 9, 2016

A new update to the mobile app for the Merck Manual for Healthcare Professionals is broadening access to the reference guide. 

September 8, 2016

Last flu season, Wegmans administered more than 75,000 flu vaccinations.

September 8, 2016

In addition to a $0 copay for eligible patients, the program includes free 30-day samples to allow patients to start treatment immediately, as well as a support line for benefit verification and prior authorizations. Additional prior authorization assistance is provided. 

September 6, 2016

The acquisition saw Allergan pay RetroSense Therapeutics a $60 million upfront payment, with the promise of potential regulatory and commercialization milestone payments for the company’s lead development program, RST-001 — a potential therapy for retinitis pigmentosa. 

September 6, 2016
The ads highlight the stories of patients and their loved ones and will run across the country for the next several weeks,
September 6, 2016
The expanded indication for Amgen's biologic was granted by the Food and Drug Administration under accelerated approval. 
 
September 6, 2016

The first set of print and digital ads star Ed, a colon cancer survivor, and other new print ads feature Roxanne, who has lived with heart disease and received a heart transplant.

September 1, 2016

The company also announced a number of other executive-level changes, effective immediately.

August 31, 2016

The U.S. Food and Drug Administration has approved Erelzi, (etanercept-szzs) for multiple inflammatory diseases.

August 31, 2016

Among the changes, the FDA is requiring boxed warnings for nearly 400 products, as well as patient-focused Medication Guides for prescription opioids and benzodiazepines.

August 29, 2016

Afluria Quadrivalent is the second quadrivalent influenza vaccine that Seqirus is offering this season after the FDA approved Flucelvax Quadrivalent in May.

August 25, 2016

Amgen’s Parsabiv is aimed at treating hyperparathyroidism in adult patients with chronic kidney disease on hemodialysis.

August 25, 2016

The company has introduced a $300 savings card and increased eligibility for its patient assistance program while continuing to donate EpiPens through its EpiPen4Schools program. 

August 24, 2016

Pfizer will pay $550 million upfront to AstraZeneca upon close of the transaction and a deferred $175 million payment in January 2019 for the development and commercialization rights to five drugs.